Want to join the conversation?
$LFUS expects the $ON product lines acquisition to have EBITDA margins of more than 30%. Including amortization, interest and integration expenses, company expects the acquisition to be neutral to diluted EPS in 2016 and add to diluted EPS in 2017 and beyond.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?